| 摘要 |
The present invention relates to bacterial proteins, particularly bacterial glycoprotein polymers with a molecular weight of 116 to 158 kDa which exhibit unique immunogenic and biological activities and may be used in vaccines and in pharmaceutical compositions, e.g., for treating tumors, and as biological effectors, such as anti-proliferation agents and nucleases. |
